It’s a privilege to have met Daniel O’Day again, Chairman & CEO of Gilead Sciences Inc. at a meeting post CROI 2025 in Forster City, CA. Our conversation highlighted the importance of continued innovation and collaboration in HIV prevention and…
I wish to share with you my notes following Dr. Flavia Matovu Kiweewa‘s appearance on Radio One FM 90‘s Health Net show over the weekend ahead of #WorldAidsDay, to discuss Gilead Sciences twice yearly injectable Lenacapavir (LEN). Read More>>>
It was a pleasure catching up with Gilead Sciences‘ PURPOSE 1 protocol leadership following my presentation at the recently concluded CROI 2025 meeting in SanFrancisco. Read More>>>
This year’s cohort is exceptional. It marks the first time we are including women leaders from Southern African states, thereby expanding our impact beyond East Africa. Join me in welcoming this incredible group of 30 women leaders who are committed…
At CROI 2025, Dr. Flavia Matovu Kiweewa from MU-JHU Care LTD | MU-JHU Research Collaboration presented impactful research highlighting the power of choice in HIV prevention. Her study focused on F/TAF, a daily oral Pre-Exposure Prophylaxis (PrEP) option that offers…
Dr. Kiweewa highlighted the continued importance of traditional HIV prevention methods, including the ABC approach (Abstinence, Be faithful, and Condom use), while encouraging the adoption of new scientific interventions like Lenacapavir.Details here: Read More:>>>>>
Read more>>>>>
Read more>>>>
Dr Matovu supervised the research site that discovered that the vaginal ring can work Read more>>>>>>>
Uganda is set to take significant strides in the global fight against HIV, as the Ministry of Health (MOH) sets its sights on integrating new, cutting-edge prevention methods into the country’s National HIV Combination Prevention Strategy. With the aim of…
